Zinc finger E‐box binding homeobox‐1 (Zeb1) drives anterograde lysosome trafficking and tumor cell invasion via upregulation of Na+/H+ Exchanger‐1 (NHE1)

Tumor cell invasion through the extracellular matrix is facilitated by the secretion of lysosome‐associated proteases. As a common mechanism for secretion, lysosomes must first traffic to the cell periphery (anterograde trafficking), consistent with invasive cells often containing lysosomes closer to the plasma membrane compared to non‐invasive cells. Epithelial to mesenchymal transition (EMT) is a transcriptionally driven program that promotes an invasive phenotype, and Zeb1 is one transcription factor that activates the mesenchymal gene expression program. The role of lysosome trafficking in EMT‐driven invasion has not been previously investigated. We found that cells with increased levels of Zeb1 displayed lysosomes located closer to the cell periphery and demonstrated increased protease secretion and invasion in 3‐dimensional (3D) cultures compared to their epithelial counterparts. Additionally, preventing anterograde lysosome trafficking via pharmacological inhibition of Na+/H+ exchanger 1 (NHE1) or shRNA depletion of ADP‐ribosylation like protein 8b (Arl8b) reversed the invasive phenotype of mesenchymal cells, thus supporting a role for lysosome positioning in EMT‐mediated tumor cell invasion. Immunoblot revealed that expression of Na+/H+ exchanger 1 correlated with Zeb1 expression. Furthermore, we found that the transcription factor Zeb1 binds to the Na+/H+ exchanger 1 promoter, suggesting that Zeb1 directly controls Na+/H+ transcription. Collectively, these results provide insight into a novel mechanism regulating Na+/H+ exchanger 1 expression and support a role for anterograde lysosome trafficking in Zeb1‐driven cancer progression. © 2016 Wiley Periodicals, Inc.

[1]  J. Cardelli,et al.  The Arf-like GTPase Arl8b is essential for three-dimensional invasive growth of prostate cancer in vitro and xenograft formation and growth in vivo , 2016, Oncotarget.

[2]  A. Postigo,et al.  ZEB1 and TCF4 reciprocally modulate their transcriptional activities to regulate Wnt target gene expression , 2015, Oncogene.

[3]  J. Cardelli,et al.  The histone deacetylase inhibitor cambinol prevents acidic pHe-induced anterograde lysosome trafficking independently of sirtuin activity , 2015, Biochemistry and biophysics reports.

[4]  Michael W. Davidson,et al.  Actin Depletion Initiates Events Leading to Granule Secretion at the Immunological Synapse , 2015, Immunity.

[5]  Hailin Tang,et al.  ZEB1 transcriptionally regulated carbonic anhydrase 9 mediates the chemoresistance of tongue cancer via maintaining intracellular pH , 2015, Molecular Cancer.

[6]  Joshua J. Steffan,et al.  Supporting a Role for the GTPase Rab7 in Prostate Cancer Progression , 2014, PloS one.

[7]  R. Cardone,et al.  Protease activity at invadopodial focal digestive areas is dependent on NHE1-driven acidic pHe. , 2014, Oncology reports.

[8]  Fangfang Zhang,et al.  Epstein–Barr virus‐induced epigenetic alterations following transient infection , 2013, International journal of cancer.

[9]  A. Postigo,et al.  ZEB1 Promotes Invasiveness of Colorectal Carcinoma Cells through the Opposing Regulation of uPA and PAI-1 , 2013, Clinical Cancer Research.

[10]  G. Woude,et al.  Abstract 326: Aneuploidy-driven clonal diversification underlies tumor phenotype switching , 2012 .

[11]  J. Norman,et al.  Rab25 and CLIC3 Collaborate to Promote Integrin Recycling from Late Endosomes/Lysosomes and Drive Cancer Progression , 2012, Developmental cell.

[12]  S. Munro,et al.  Arl8 and SKIP Act Together to Link Lysosomes to Kinesin-1 , 2011, Developmental cell.

[13]  D. Larson,et al.  Cortactin phosphorylation regulates cell invasion through a pH-dependent pathway , 2011, The Journal of cell biology.

[14]  R. Vessella,et al.  LIV-1 Promotes Prostate Cancer Epithelial-to-Mesenchymal Transition and Metastasis through HB-EGF Shedding and EGFR-Mediated ERK Signaling , 2011, PloS one.

[15]  Alissa M. Weaver,et al.  Cortactin Controls Cell Motility and Lamellipodial Dynamics by Regulating ECM Secretion , 2011, Current Biology.

[16]  S. Courtneidge,et al.  The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and function , 2011, Nature Reviews Molecular Cell Biology.

[17]  N. Hacohen,et al.  Lysosomal Trafficking, Antigen Presentation, and Microbial Killing Are Controlled by the Arf-like GTPase Arl8b , 2011, Immunity.

[18]  P. Nelson,et al.  Metastatic progression of prostate cancer and e-cadherin regulation by zeb1 and SRC family kinases. , 2011, The American journal of pathology.

[19]  Cahir J. O'Kane,et al.  Lysosomal positioning coordinates cellular nutrient responses , 2011, Nature Cell Biology.

[20]  Valerie M. Weaver,et al.  The extracellular matrix at a glance , 2010, Journal of Cell Science.

[21]  F. Domann,et al.  ZEB1 Coordinately Regulates Laminin-332 and β4 Integrin Expression Altering the Invasive Phenotype of Prostate Cancer Cells* , 2010, The Journal of Biological Chemistry.

[22]  A. Paradiso,et al.  NHE1 promotes invadopodial ECM proteolysis through acidification of the peri‐invadopodial space , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  Joshua J. Steffan,et al.  HGF-induced invasion by prostate tumor cells requires anterograde lysosome trafficking and activity of Na+-H+ exchangers , 2010, Journal of Cell Science.

[24]  Joshua J. Steffan,et al.  Thiazolidinediones Induce Rab7–RILP–MAPK‐Dependent Juxtanuclear Lysosome Aggregation and Reduce Tumor Cell Invasion , 2010, Traffic.

[25]  Joshua J. Steffan,et al.  Na+/H+ Exchangers and RhoA Regulate Acidic Extracellular pH‐Induced Lysosome Trafficking in Prostate Cancer Cells , 2009, Traffic.

[26]  Thomas B Bair,et al.  ZEB1 enhances transendothelial migration and represses the epithelial phenotype of prostate cancer cells. , 2009, Molecular biology of the cell.

[27]  Stephen J. Weiss,et al.  Protease-dependent versus -independent cancer cell invasion programs: three-dimensional amoeboid movement revisited , 2009, The Journal of cell biology.

[28]  Samy Lamouille,et al.  TGF-β-induced epithelial to mesenchymal transition , 2009, Cell Research.

[29]  Bonnie F. Sloane,et al.  Lysosomal cathepsin B participates in the podosome-mediated extracellular matrix degradation and invasion via secreted lysosomes in v-Src fibroblasts. , 2008, Cancer research.

[30]  Peter Friedl,et al.  Tube travel: the role of proteases in individual and collective cancer cell invasion. , 2008, Cancer research.

[31]  Ming-Jer Tang,et al.  Epithelial-Mesenchymal Transition in Cervical Cancer: Correlation with Tumor Progression, Epidermal Growth Factor Receptor Overexpression, and Snail Up-Regulation , 2008, Clinical Cancer Research.

[32]  Zhi-Ren Liu,et al.  Epithelial to mesenchymal transition (EMT) in human prostate cancer: lessons learned from ARCaP model , 2008, Clinical & Experimental Metastasis.

[33]  Bonnie F. Sloane,et al.  Visualizing Protease Activity in Living Cells: From Two Dimensions to Four Dimensions , 2008, Current protocols in cell biology.

[34]  A. Dimmler,et al.  The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer. , 2008, Cancer research.

[35]  R. Foisner,et al.  The transcription factor ZEB1 (δEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity , 2007, Oncogene.

[36]  J. Callahan,et al.  The Arf-family protein, Arl8b, is involved in the spatial distribution of lysosomes. , 2006, Biochemical and biophysical research communications.

[37]  Brian P Ceresa,et al.  rab7 Activity Affects Epidermal Growth Factor:Epidermal Growth Factor Receptor Degradation by Regulating Endocytic Trafficking from the Late Endosome* , 2006, Journal of Biological Chemistry.

[38]  R. Cardone,et al.  The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis , 2005, Nature Reviews Cancer.

[39]  G. Berx,et al.  DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells , 2005, Oncogene.

[40]  H. Miyake,et al.  Serum level of cathepsin B and its density in men with prostate cancer as novel markers of disease progression. , 2004, Anticancer research.

[41]  M. Solaiyappan,et al.  Extracellular acidification alters lysosomal trafficking in human breast cancer cells. , 2003, Neoplasia.

[42]  Bonnie F. Sloane,et al.  Pericellular cathepsin B and malignant progression , 2003, Cancer and Metastasis Reviews.

[43]  N. Nakamura,et al.  KIF1Bbeta2, capable of interacting with CHP, is localized to synaptic vesicles. , 2002, Journal of biochemistry.

[44]  J. Thiery.  Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.

[45]  Jacques Neefjes,et al.  The Rab7 effector protein RILP controls lysosomal transport by inducing the recruitment of dynein-dynactin motors , 2001, Current Biology.

[46]  E. Caler,et al.  Plasma Membrane Repair Is Mediated by Ca2+-Regulated Exocytosis of Lysosomes , 2001, Cell.

[47]  M. Shigekawa,et al.  Calcineurin Homologous Protein as an Essential Cofactor for Na+/H+ Exchangers* , 2001, The Journal of Biological Chemistry.

[48]  D. Barber,et al.  Direct binding of the Na--H exchanger NHE1 to ERM proteins regulates the cortical cytoskeleton and cell shape independently of H(+) translocation. , 2000, Molecular cell.

[49]  S. Caldeira,et al.  Na+/H+ exchanger‐dependent intracellular alkalinization is an early event in malignant transformation and plays an essential role in the development of subsequent transformation‐associated phenotypes , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[50]  Bonnie F. Sloane,et al.  Unraveling the role of proteases in cancer. , 2000, Clinica chimica acta; international journal of clinical chemistry.

[51]  K. Bernd,et al.  The EF-hand Ca(2+)-binding protein p22 associates with microtubules in an N-myristoylation-dependent manner. , 1999, Molecular biology of the cell.

[52]  N. Hirokawa,et al.  Targeted Disruption of Mouse Conventional Kinesin Heavy Chain kif5B, Results in Abnormal Perinuclear Clustering of Mitochondria , 1998, Cell.

[53]  Bonnie F. Sloane,et al.  Immunohistochemical localization of cathepsin B in neoplastic human prostate , 1995, The Prostate.

[54]  Y. Nabeshima,et al.  The delta-crystallin enhancer-binding protein delta EF1 is a repressor of E2-box-mediated gene activation , 1994, Molecular and cellular biology.

[55]  A. Jemal,et al.  Cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.

[56]  Bonnie F. Sloane,et al.  Live-cell imaging of tumor proteolysis: impact of cellular and non-cellular microenvironment. , 2012, Biochimica et biophysica acta.

[57]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.